🔎 Trials Near Me

Beranda › Meningioma › New York

Uji klinis Meningioma di New York

9 studi untuk Meningioma mencari peserta di lokasi di New York.

Kota di New York

Teks studi resmi (Bahasa Inggris)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

  • Glens Falls Hospital, Glens Falls
  • Northwell Health/Center for Advanced Medicine, Lake Success
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • dan 2 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT02523014

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

  • NYU Lagone Health, New York
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06955169

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

  • Memorial Sloan-Kettering Cancer Center, New York
  • Mayo Clinic_Rochester, Rochester
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07428616

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

  • New York University Langone Medical Center, New York
Menerima pesertaFase 2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT04374305

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

  • NYU- Langone Health, New York
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT07533942

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

  • Albany Medical Center, Albany
  • SUNY Upstate Medical Center, Syracuse
  • Montefiore Einstein, The Bronx
  • dan 1 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT04427384

Cabozantinib for Patients With Recurrent or Progressive Meningioma

  • Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT05425004

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

  • New York-Presbyterian/Weill Cornell Medical Center, New York
Menerima pesertaFase 4
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT06377371

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

  • Weill Cornell Medicine, New York
Menerima pesertaFase 4
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 21 Nov 2025 · NCT04081701

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.